COVID-19 vaccine acceptance and hesitancy in N’Djamena, Chad: A cross-sectional study of patients, community members, and healthcare workers
Open Access
- 27 June 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 2 (6), e0000608
- https://doi.org/10.1371/journal.pgph.0000608
Abstract
As of March 2022, the COVID-19 vaccination rate in Chad approximated 1%. There are no published reports of COVID-19 vaccine hesitancy or beliefs in Chad. We aimed to study COVID-19 vaccine acceptance and hesitancy among community members, patients, and health care workers in urban Chad. We recruited a prospective convenience sample of adult patients, community members, and healthcare workers from N’Djamena, Chad between August–October 2021. Participants completed a 15-minute, 25-question survey instrument exploring demographic, social, and clinical variables related to COVID-19 and an adapted WHO SAGE Vaccine Hesitancy Survey. Primary outcomes were vaccine acceptance and vaccine hesitancy. Regression models were fit to assess associations between Vaccine Hesitancy Scale (VHS) scores, ranging from 10 (least hesitant) to 50 (most hesitant) points, and pre-selected variables of interest. An inductive thematic analysis was used to analyze the qualitative vaccine hesitancy responses. Of 508 participants (32% female; mean age 32 years), 162 were patients, 153 were community members, and 193 were healthcare workers. COVID-19 vaccine acceptance was significantly higher among patients (67%) than community members (44%) or healthcare workers (47%), p < .001. The average VHS score was 29 points (patients = 27.0, community members = 28.9, healthcare workers = 29.4), and more than one-third of participants were classified as highly vaccine hesitant (score >30 points). Knowing someone who died from COVID-19, believing local healthcare workers support vaccination, trusting the government, having a higher socioeconomic status (i.e. having electricity), and reporting medical comorbidities were each associated with less vaccine hesitancy (all p < .05). The vaccine concerns most frequently endorsed were: vaccine side effects (48%), efficacy (38%), safety (34%), concerns about the pharmaceutical industry (27%), and lack of government trust (21%). Four main themes arose from qualitative vaccine hesitancy responses (n = 116): education, trust, clinical concerns, and misinformation and false beliefs. Overall, COVID-19 vaccine acceptance was low, including among health care workers, and reasons for vaccine hesitancy were broad. We detail the most commonly reported concerns of urban Chadians for receiving the COVID-19 vaccine; we also identify subgroups most likely to endorse vaccine hesitancy. These analyses may inform future vaccination outreach campaigns in N’Djamena.This publication has 17 references indexed in Scilit:
- COVID-19 and vaccine hesitancy: A longitudinal studyPLOS ONE, 2021
- Vaccine Hesitancy: COVID-19 and Influenza Vaccine Willingness among Parents in Wuxi, China—A Cross-Sectional StudyVaccines, 2021
- COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance RatesVaccines, 2021
- Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19JAMA Network Open, 2020
- Short communication on the use of a free rabies hotline service in ChadActa Tropica, 2020
- Current challenges and proposed solutions to the effective implementation of the RTS, S/AS01 Malaria Vaccine Program in sub-Saharan Africa: A systematic reviewPLOS ONE, 2018
- Vaccine hesitancy among mobile pastoralists in Chad: a qualitative studyInternational Journal for Equity in Health, 2018
- Measuring vaccine hesitancy: The development of a survey toolVaccine, 2015
- HPV vaccine acceptability in Africa: A systematic reviewPreventive Medicine, 2014
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992